Further studies are needed to elucidate the actual mechanism behind the contribution of MPO to the development of atherosclerosis and to assess the potential of apoA-I/apoA-II heterodimers as a biomarker for estimating the anti-inflammatory ability of HDL. The gene discussed is APOA2; the disease is atherosclerosis.